1. IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells
   Zihui Li et al, 2024, Cellular Signalling CrossRef
2. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation
   Peter Gál et al, 2022, Histochemistry and Cell Biology CrossRef
3. TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway
   Qiuli Jiang et al, 2023, Immunity, Inflammation and Disease CrossRef
4. Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance
   Marta Ostrowska-Lesko et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
5. Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs
   Akey Krishna Swaroop et al, 2024, Cytokine & Growth Factor Reviews CrossRef
6. Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade
   Pengyuan Kang et al, 2023, Cytokine CrossRef
7. The potential role of interleukins and interferons in ovarian cancer
   Huldani Huldani et al, 2023, Cytokine CrossRef
8. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
   Antonio Hrvat et al, 2024, Frontiers in Immunology CrossRef
9. The Effects of Natural Epigenetic Therapies in 3D Ovarian Cancer and Patient-Derived Tumor Explants: New Avenues in Regulating the Cancer Secretome
   Rebeca Kelly et al, 2023, Biomolecules CrossRef
10. The prohibitin-binding compound fluorizoline induces the pro-inflammatory cytokines interleukin-8 and interleukin-6 through the activation of JNK and p38 MAP kinases
    Ismael Sánchez-Vera et al, 2023, Biochemical Pharmacology CrossRef
11. Interleukin-6 Family of Cytokines in Cancers
    Iwona Zaporowska-Stachowiak et al, 2024, Journal of Interferon & Cytokine Research CrossRef